Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats
- 1 May 1998
- journal article
- Published by Elsevier in Kidney International
- Vol. 53 (5) , 1305-1313
- https://doi.org/10.1046/j.1523-1755.1998.00867.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Human Kallikrein Gene Delivery Attenuates Hypertension, Cardiac Hypertrophy, and Renal Injury in Dahl Salt-Sensitive RatsHuman Gene Therapy, 1998
- Gene Therapy in Hypertension: Adenovirus-Mediated Kallikrein Gene Delivery in Hypertensive RatsHuman Gene Therapy, 1997
- Role of Kinins in the Renal Response to Enalaprilat in Normotensive and Hypertensive RatsHypertension, 1996
- Gentamicin nephrotoxicity in humans and animals: Some recent researchGeneral Pharmacology: The Vascular System, 1995
- Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.Journal of Clinical Investigation, 1995
- Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.Hypertension, 1994
- Pathogenic factors in aminoglycoside-induced nephrotoxicityToxicology Letters, 1990
- Early Acute Effects of Mercuric Chloride on Synthesis and Release of Kallikrein and on Distal Tubular Morphology of Rat Renal Cortical SlicesKidney and Blood Pressure Research, 1990
- A gene for high urinary kallikrein may protect against hypertension in Utah kindreds.Hypertension, 1989
- Aminoglycoside nephrotoxicityKidney International, 1988